Butyrylcholinesterase anticorps
Aperçu rapide pour Butyrylcholinesterase anticorps (ABIN7246055)
Antigène
Voir toutes Butyrylcholinesterase (BCHE) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Polyclonal Antibody
-
Purification
- Antigen affinity purification
-
Immunogène
- Fusion protein of human BCHE
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IHC 1:40-1:200, ELISA 1:5000-1:10000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.6 mg/mL
-
Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- Butyrylcholinesterase (BCHE)
-
Autre désignation
- BCHE
-
Sujet
- Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage.
-
UniProt
- P06276
-
Pathways
- Peptide Hormone Metabolism
Antigène
-